Markets.News

CHEK  CHECK-CAP LTD

+ add to watchlist

$2.56

check-cap is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose x-rays for crc screening. the check-cap device requires no bowel preparation or invasive procedures, and is designed to detect clinically significant polyps with a high degree of sensitivity. check-cap's advanced technology has been proven in animals, and is designed to offer several advantages compared to current screening procedures. founded in early 2005, check-cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology, who have been developing a multi-disciplinary imaging solution for imaging and screening of the colon. the system includes a capsule, a receiver, proprietary imaging software and an associated database for web based access and analysis. check-cap's advanced technology has been proven in animals and promises to offer several significant advantages compared to other colo

Mkt Cap: $11.03M

52 Week High: $3.04

P/E: 0.00

52 Week Low: $0.56

Dividend: $0.00

Shares Outstanding:

This news is delayed by 15 minutes, sign up now to get live news & full features.